ARUP's Laboratory Test Directory

Factor V Leiden (F5) R506Q Mutation : 0097720
[ image for: Patient History For Molecular Genetics]
Patient History For Molecular Genetics
  


Mnemonic: FACV

Methodology: Polymerase Chain Reaction/Fluorescence Monitoring
Performed: Sun-Sat
Reported: 2-4 days
Specimen Required: Collect:  One 3 mL lavender (EDTA), pink (K2EDTA), or yellow (ACD Solution A or B).

Transport:   3 mL whole blood at 2-8°C. (Min: 1 mL)

Pediatric Collection/Transport:  1 mL whole blood (lavender EDTA) at 2-8°C. Do not freeze.

Unacceptable Conditions:  Serum, frozen whole blood, and severely hemolyzed samples.

Stability:  Ambient: 3 days; Refrigerated: 1 week; Frozen: Unacceptable
Reference Interval:
Negative: This sample is negative for factor V Leiden, R506Q mutation.
Interpretive Data: Background Information for Factor V Leiden (F5) R506Q Mutation
Characteristics:
Factor V Leiden mutation is the most common cause of inherited thrombophilia and accounts for over 90 percent of activated protein C resistance. The expression of Factor V Leiden thrombophilia is impacted by coexisting genetic thrombophilic disorders, acquired thrombophilic disorders (malignancy, hyperhomocysteinemia, high factor VIII levels), and circumstances including: pregnancy, oral contraceptive use, hormone replacement therapy, selective estrogen receptor modulators, travel, central venous catheters, surgery, transplantation and advanced age.
Incidence:
Approximately 5 percent of Caucasians, 2 percent of Hispanics, 1 percent of African Americans and Native Americans and 0.5 percent of Asians are heterozygous; homozygosity occurs in 1 in 5000 individuals.
Inheritance:
Incomplete autosomal dominant.
Penetrance:
Lifetime risk of thrombosis is 10 percent for heterozygotes and 80 percent for homozygotes.
Cause:
A deleterious F5 gene mutation R506Q (1691G>A). Note: Standardized nomenclature for the Factor V Leiden mutation is c.1601G>A (p.Arg534Gln).
Clinical Sensitivity and Specificity:
99 percent.
Methodology:
Polymerase chain reaction and fluorescence monitoring.
Analytical Sensitivity and Specificity:
99 percent.
Limitations:
Rare diagnostic errors can occur due to primer site mutations. F5 gene mutations, other than R506Q, will not be detected.





Please refer to Statement C in the Compliance Statements section in the front of the Laboratory Test Directory.
Note: This test is not recommended for nonsymptomatic patients under 18 years of age.
CPT Code(s): 83891 Isolation; 83898 Amplification; 83896 Nucleic acid probes; 83912 Interpretation and report - Additional CPT code modifiers may be required for procedures performed to test for oncologic or inherited disorders.
 
 

 

 

 
All ARUP Sites:        www.aruplab.com     ·     www.arupconsult.com     ·     www.arup.utah.edu     ·     www.childx.org     ·     www.utahblood.org